Markedly Enhanced Susceptibility to Experimental Autoimmune Myasthenia Gravis in the Absence of Decay-Accelerating Factor Protection
Journal of Clinical Investigation - United States
doi 10.1172/jci0216086
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 1, 2002
Authors
Publisher
American Society for Clinical Investigation